Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study
Japanese Journal of Clinical Oncology · 2026
DOI: 10.1093/jjco/hyaf176 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Japanese Journal of Clinical Oncology, 2026. Verfasst von Takanori Yokoyama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, National Hospital Organization (NHO) Shikoku Cancer Center, Ko-160 Minami-Umemoto cho, Matsuyama City, Ehime 791-…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Ovarian Neoplasms, Neoplastic Syndromes, Hereditary. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
To evaluate the current state of hereditary cancer syndrome management in patients with ovarian and endometrial cancer and to identify the barriers to uptake of genetic testing.
Methods
We conducted a cross-sectional multicenter study at five regional cancer centers in Japan, including 229 patients with ovarian cancer and 454 with endometrial cancer treated between January 2021 and December 2022. We assessed the proportion of patients who received information about hereditary cancer syndromes from gynecologists, underwent genetic counseling with genetic experts, and completed genetic testing; in addition, we explored the barriers to testing uptake.
Results
Among patients with ovarian cancer, 152 (66.4%) received information about hereditary cancer syndromes from their gynecologists, with 61 (26.6%) subsequently receiving genetic counseling and 58 (25.3%) undergoing genetic testing. By contrast, patients with endometrial cancer demonstrated markedly lower rates: only 76 (16.7%) received initial information, 22 (5.3%) accessed genetic counseling, and 13 (2.9%) completed genetic testing. Among patients who received information about hereditary cancer syndromes from their gynecologists, 38% with ovarian cancer and 14% with endometrial cancer underwent genetic testing. Among patients identified as high-risk for hereditary cancer syndromes through tumor profiling, 27.6% (8/29) with ovarian cancer and 70.6% (12/17) with endometrial cancer did not undergo genetic testing. Patient disinterest was the primary barrier to genetic testing among high-risk individuals.
Conclusions
The barriers to uptake of genetic testing arise primarily from inadequate provider communication and patient disinterest in hereditary cancer syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, National Hospital Organization (NHO) Shikoku Cancer Center, Ko-160 Minami-Umemoto cho, Matsuyama City, Ehime 791-0280, Japan.
- Department of Cancer Genomic Medicine and Hereditary Tumors, NHO Shikoku Cancer Center, Ko-160 Minami-Umemoto cho, Matsuyama City, Ehime 791-0280, Japan.
- Clinical Research Center, NHO Shikoku Cancer Center, Ko-160 Minami-Umemoto cho, Matsuyama City, Ehime 791-0280, Japan.
- Department of Obstetrics and Gynecology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon City, Ehime 791-0295, Japan.
- Department of Obstetrics and Gynecology, Tokushima University Graduate School of Medicine, 2-50-1 Kuramoto cho, Tokushima City, Tokushima 770-0042, Japan.
- Department of Obstetrics and Gynecology, Tokushima Prefectural Central Hospital, 1-10-3 Kuramoto cho, Tokushima City, Tokushima 770-8539, Japan.
ORCID-Profile: Takanori Yokoyama, Mika Okazawa-Sakai, Kazuhiro Takehara
Zitieren
APA
Yokoyama, T., Yamamoto, Y., Okazawa-Sakai, M., Yamashita, N., Usami, T., Matsumoto, M., Inui, H., Nishimura, M., Tanaka, T., Ushiwaka, T., & Takehara, K. (2026). Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf176
Vancouver
Yokoyama T, Yamamoto Y, Okazawa-Sakai M, Yamashita N, Usami T, Matsumoto M, et al. Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study. Japanese Journal of Clinical Oncology. 2026. doi:10.1093/jjco/hyaf176
BibTeX
@article{Yokoyama2026,
author = {Yokoyama, Takanori and Yamamoto, Yasuko and Okazawa-Sakai, Mika and Yamashita, Natsumi and Usami, Tomoka and Matsumoto, Mihoko and Inui, Hiroaki and Nishimura, Masato and Tanaka, Tamaki and Ushiwaka, Takashi and Takehara, Kazuhiro},
title = {Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study},
journal = {Japanese Journal of Clinical Oncology},
year = {2026},
doi = {10.1093/jjco/hyaf176}
}
EUVIMED